Opportunities and Challenges With Lung Cancer Screening Following COVID-19

Video

James L. Mulshine, MD, professor of internal medicine, as well as associate director of the Institute of Translation Medicine at Rush University, shared some of the challenges that have stemmed from the COVID-19 pandemic and how it has impacted lung cancer screening in the United States.

James L. Mulshine, MD, professor of internal medicine, as well as associate director of the Institute of Translation Medicine at Rush University, shared some of the challenges that have stemmed from the COVID-19 pandemic and how it has impacted lung cancer screening in the United States.

In this segment, Mulshine also highlights how the public health crisis led to opportunities for improvement in the lung cancer landscape.

Related Videos
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Related Content